Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2025-03-08 Governance Information
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
Other.pdf
Governance Information Classification · 90% confidence The document is the full text of Profound Medical Corp.’s Long Term Incentive Plan outlining definitions, administration, and terms for RSUs and DSUs. It is not a financial report, earnings release, or proxy statement itself but rather an internal governance policy detailing the company’s equity compensation arrangements. This aligns with Governance Information (CGR).
2025-03-08 English
Cover letter.pdf
Report Publication Announcement Classification · 90% confidence The document is a “Notice to Public” pursuant to CSA Staff Notice 51-338, informing stakeholders that the company has filed its Annual Report on Form 10-K and listing the exhibits incorporated by reference along with their filing details. It is not the 10-K itself but an announcement of its filing and related exhibit disclosures. This fits the definition of a Report Publication Announcement (RPA), which covers announcements about the release or publication of company reports.
2025-03-08 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 94% confidence The document is a standardized Form 13-501F1 filed with the Alberta Securities Commission to certify market values and calculate a participation fee. It is neither an annual or quarterly report, nor a corporate earnings/management discussion, nor a board change or dividend notice. It is a regulatory submission required by securities regulators, best categorized under the fallback “Regulatory Filings” (RNS).
2025-03-08 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 90% confidence The document is a completed OSC Form 13-502F1 for calculating and certifying the participation fee of a Canadian reporting issuer. It is a regulatory form filed with the Ontario Securities Commission, not a financial report (e.g., 10-K, IR), earnings release, or investor presentation. It does not announce board changes, dividends, share issues, or legal proceedings. As a miscellaneous regulatory submission, it falls under the fallback category "Regulatory Filings" (RNS).
2025-03-08 English
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Section 302 certification signed by the Principal Executive Officer. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report like a 10-K, should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive data. FY 2024
2025-03-08 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Section 302 certification signed by the Principal Financial Officer. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report like a 10-K, must be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. FY 2024
2025-03-08 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.